David Kershaw

1.5k total citations
24 papers, 928 citations indexed

About

David Kershaw is a scholar working on Nephrology, Cardiology and Cardiovascular Medicine and Molecular Biology. According to data from OpenAlex, David Kershaw has authored 24 papers receiving a total of 928 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Nephrology, 7 papers in Cardiology and Cardiovascular Medicine and 5 papers in Molecular Biology. Recurrent topics in David Kershaw's work include Renal Diseases and Glomerulopathies (8 papers), Blood Pressure and Hypertension Studies (7 papers) and Sodium Intake and Health (3 papers). David Kershaw is often cited by papers focused on Renal Diseases and Glomerulopathies (8 papers), Blood Pressure and Hypertension Studies (7 papers) and Sodium Intake and Health (3 papers). David Kershaw collaborates with scholars based in United States, China and Japan. David Kershaw's co-authors include Roger C. Wiggins, Meera Goyal, Jocelyn Wiggins, Bryan L. Wharram, Yeong Hoon Kim, David M. Kurnit, Lawrence B. Holzman, Albert P. Rocchini, Esther Yoon and Sarah J. Clark and has published in prestigious journals such as Contemporary Sociology A Journal of Reviews, PLoS ONE and PEDIATRICS.

In The Last Decade

David Kershaw

23 papers receiving 895 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Kershaw United States 13 548 232 141 111 94 24 928
Eva Šimková Czechia 16 258 0.5× 131 0.6× 53 0.4× 78 0.7× 57 0.6× 38 697
Alexander Hamilton United Kingdom 14 129 0.2× 187 0.8× 143 1.0× 200 1.8× 51 0.5× 62 846
D. Cohen United Kingdom 13 215 0.4× 373 1.6× 32 0.2× 78 0.7× 54 0.6× 48 1.4k
Alexa Meara United States 15 270 0.5× 151 0.7× 49 0.3× 51 0.5× 9 0.1× 49 1.2k
Purna Mukhopadhyay United States 12 141 0.3× 96 0.4× 34 0.2× 71 0.6× 9 0.1× 27 679
Румен Стефанов Bulgaria 14 105 0.2× 49 0.2× 132 0.9× 43 0.4× 56 0.6× 77 666
S. Chambers United Kingdom 13 88 0.2× 36 0.2× 77 0.5× 83 0.7× 8 0.1× 18 1.1k
Mark D. Faber United States 13 233 0.4× 35 0.2× 34 0.2× 66 0.6× 4 0.0× 23 654
Sally A. Campbell‐Lee United States 13 32 0.1× 82 0.4× 25 0.2× 78 0.7× 95 1.0× 28 805
David Martin United States 12 87 0.2× 131 0.6× 17 0.1× 126 1.1× 4 0.0× 31 630

Countries citing papers authored by David Kershaw

Since Specialization
Citations

This map shows the geographic impact of David Kershaw's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Kershaw with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Kershaw more than expected).

Fields of papers citing papers by David Kershaw

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Kershaw. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Kershaw. The network helps show where David Kershaw may publish in the future.

Co-authorship network of co-authors of David Kershaw

This figure shows the co-authorship network connecting the top 25 collaborators of David Kershaw. A scholar is included among the top collaborators of David Kershaw based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Kershaw. David Kershaw is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wickman, Larysa, Jeffrey B. Hodgin, Su Q. Wang, et al.. (2016). Podocyte Depletion in Thin GBM and Alport Syndrome. PLoS ONE. 11(5). e0155255–e0155255. 33 indexed citations
2.
Yoon, Esther, Lisa Cohn, Gary L. Freed, et al.. (2014). Use of Antihypertensive Medications and Diagnostic Tests Among Privately Insured Adolescents and Young Adults With Primary Versus Secondary Hypertension. Journal of Adolescent Health. 55(1). 73–78. 10 indexed citations
3.
Wickman, Larysa, Farsad Afshinnia, Su Q. Wang, et al.. (2013). Urine Podocyte mRNAs, Proteinuria, and Progression in Human Glomerular Diseases. Journal of the American Society of Nephrology. 24(12). 2081–2095. 106 indexed citations
4.
Sarwal, Minnie, Robert B. Ettenger, Vikas R. Dharnidharka, et al.. (2012). Complete Steroid Avoidance Is Effective and Safe in Children With Renal Transplants: A Multicenter Randomized Trial With Three-Year Follow-Up. American Journal of Transplantation. 12(10). 2719–2729. 87 indexed citations
5.
Yoon, Esther, Lisa Cohn, Albert P. Rocchini, et al.. (2012). Use of Diagnostic Tests in Adolescents With Essential Hypertension. Archives of Pediatrics and Adolescent Medicine. 166(9). 857–857. 10 indexed citations
6.
Yoon, Esther, Lisa Cohn, Albert P. Rocchini, David Kershaw, & Sarah J. Clark. (2012). Clonidine Utilization Trends for Medicaid Children. Clinical Pediatrics. 51(10). 950–955. 9 indexed citations
7.
Yoon, Esther, Lisa Cohn, Albert P. Rocchini, et al.. (2011). Antihypertensive Prescribing Patterns for Adolescents With Primary Hypertension. PEDIATRICS. 129(1). e1–e8. 38 indexed citations
8.
Martz, Karen, et al.. (2010). Mortality risk in children after renal allograft failure: a NAPRTCS study. Pediatric Nephrology. 25(12). 2517–2522. 7 indexed citations
9.
Yoon, Esther, Matthew M. Davis, Albert P. Rocchini, David Kershaw, & Gary L. Freed. (2008). Medical management of children with primary hypertension by pediatric subspecialists. Pediatric Nephrology. 24(1). 147–153. 12 indexed citations
10.
Kershaw, David, et al.. (2006). Developing clinical protocols for nursing practice: improving nephrology care for children and their families.. PubMed. 32(6). 599–606; quiz 607. 5 indexed citations
11.
Boccaccini, Marcus T., Annette Christy, Norman G. Poythress, & David Kershaw. (2005). Rediversion in Two Postbooking Jail Diversion Programs in Florida. Psychiatric Services. 56(7). 835–839. 13 indexed citations
12.
Nishibori, Yukino, Makoto Hosoyamada, Hitoshi Endou, et al.. (2004). Disease-causing missense mutations in NPHS2 gene alter normal nephrin trafficking to the plasma membrane. Kidney International. 66(5). 1755–1765. 58 indexed citations
13.
Kim, Yeong Hoon, Meera Goyal, Bryan L. Wharram, et al.. (2002). GLEPP1 Receptor Tyrosine Phosphatase (Ptpro) in Rat PAN Nephrosis. ˜The œNephron journals/Nephron journals. 90(4). 471–476. 13 indexed citations
14.
Kim, Yeong Hoon, Meera Goyal, David M. Kurnit, et al.. (2001). Podocyte depletion and glomerulosclerosis have a direct relationship in the PAN-treated rat. Kidney International. 60(3). 957–968. 332 indexed citations
15.
Rutstein, Richard M., et al.. (1998). Pediatric Primary Care Provider's Knowledge of HIV/AIDS Care. AIDS Patient Care and STDs. 12(3). 217–225. 8 indexed citations
16.
Goyal, Meera, et al.. (1998). Podocyte Phenotypes as Defined by Expression and Distribution of GLEPP1 in the Developing Glomerulus and in Nephrotic Glomeruli from MCD, CNF, and FSGS. Nephron Experimental Nephrology. 6(3). 234–244. 42 indexed citations
17.
Kershaw, David. (1982). Electron microscopy in biology, volume 1. Biochemical Education. 10(4). 157–157. 1 indexed citations
18.
Groeneveld, Lyle P., et al.. (1978). The New Jersey Income-Maintenance Experiment, Volume I: Operations, Surveys, and Administration.. Contemporary Sociology A Journal of Reviews. 7(4). 475–475. 9 indexed citations
19.
Kershaw, David, et al.. (1976). Operations, surveys, and administration. Academic Press eBooks. 2 indexed citations
20.
Kershaw, David. (1976). The New Jersey income-maintenance experiment. 78 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eva Šimková Breakdown of academic impact, for papers by Alexander Hamilton Breakdown of academic impact, for papers by D. Cohen Breakdown of academic impact, for papers by Alexa Meara Breakdown of academic impact, for papers by Purna Mukhopadhyay Breakdown of academic impact, for papers by Румен Стефанов Breakdown of academic impact, for papers by S. Chambers Breakdown of academic impact, for papers by Mark D. Faber Breakdown of academic impact, for papers by Sally A. Campbell‐Lee Breakdown of academic impact, for papers by David Martin
Rankless by CCL
2026